Pre-IPO COREE - The Business Model and the Concerns Behind
​COREE is a key connector for pediatric drugs in China, facing challenge of expanding while maintaining stability. There's signs of deterioration....
Primer: COREE (COREE HK) - Apr 2026
COREE is a leading integrated healthcare solutions provider in China with a strategic focus on the pediatric and bio-health sectors, poised for...
COREE Co Pre-IPO Tearsheet
​COREE (COREE HK) plans to raise over US$100m in Hong Kong IPO, led by CICC. A key player in China's healthcare industry, specializing in pediatric...
Aequitas: ECM Weekly (19 January 2026)- Montage, Eastroc, Longcheer, Busy Ming, Sunway, Amagi, Wuxi
Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
No more insights